Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Cresco Labs Inc. (CRLBF : OTC)

• Company Description    Cresco Labs Inc. is an integrated multistate cannabis operators principally in the United States. Its brands are designed to meet the needs of all consumer segments and comprised of brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Cresco Labs Inc. is based in CHICAGO. Number of Employees: 2,900

• Price / Volume Information    Yesterday's Closing Price: $0.94 Daily Weekly Monthly 20 Day Moving Average: 1,202,665 shares Shares Outstanding: 502.76 (millions) Market Capitalization: $472.14 (millions) Beta: 1.59 52 Week High: $2.30 52 Week Low: $0.43 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.44% -5.72% 12 Week -15.40% -22.61% Year To Date -23.65% -30.33%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 600 W Fulton St Suite 800 - CHICAGO,IL 60661 USA ph: 312-929-0993 fax: - investors@crescolabs.com http://www.crescolabs.com

• General Corporate Information    Officers Charles Bachtell - Chief Executive Officer and Director Thomas Manning - Chairman and Director Gregory Butler - President Sharon Schuler - Chief Financial Officer Robert M. Sampson - Director Peer Information Cresco Labs Inc. (BJCT) Cresco Labs Inc. (CADMQ) Cresco Labs Inc. (APNO) Cresco Labs Inc. (UPDC) Cresco Labs Inc. (IMTIQ) Cresco Labs Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 22587M106 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 502.76 Most Recent Split Date: (:1) Beta: 1.59 Market Capitalization: $472.14 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.09 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.93 Price/Cash Flow: 24.39 Price / Sales: 0.74 EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: -100.00% Sales Growth vs. Year Ago Period: -8.71% vs. Previous Quarter: -6.33% ROE 03/31/26 - -17.98 12/31/25 - -16.61 09/30/25 - -14.25 ROA 03/31/26 - -4.29 12/31/25 - -4.25 09/30/25 - -3.90 Current Ratio 03/31/26 - 2.51 12/31/25 - 2.59 09/30/25 - 2.49 Quick Ratio 03/31/26 - - 12/31/25 - 1.60 09/30/25 - 1.54 Operating Margin 03/31/26 - -8.39 12/31/25 - -8.42 09/30/25 - -7.79 Net Margin 03/31/26 - -20.90 12/31/25 - -20.65 09/30/25 - -7.79 Pre-Tax Margin 03/31/26 - -15.17 12/31/25 - -14.55 09/30/25 - -0.78 Book Value 03/31/26 - 0.49 12/31/25 - 0.50 09/30/25 - 0.95 Inventory Turnover 03/31/26 - 3.29 12/31/25 - 3.61 09/30/25 - 3.92 Debt-to-Equity 03/31/26 - 1.78 12/31/25 - 1.72 09/30/25 - 1.28 Debt-to-Capital 03/31/26 - 64.09 12/31/25 - 63.29 09/30/25 - 56.07

Powered by Zacks Investment Research ©